Related Experiment Videos
Effects of atypical infections with Mycoplasma and Chlamydia on asthma
1Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, 4309 Medical Park Drive, Durham, NC 27704, USA.
Abstract:
Mycoplasma pneumoniae and Chlamydophila pneumoniae are atypical bacteria that are frequently found in patients with asthma. A definitive diagnosis of infection is often difficult to obtain because of limitations with sampling and detection. Numerous animal studies have outlined mechanisms by which these infections may promote allergic lung inflammation and airway remodeling. In addition, there is mounting evidence from human studies suggesting that atypical bacterial infections contribute to asthma exacerbations, chronic asthma, and disease severity. The role of antimicrobials directed against atypical bacteria in asthma is still under investigation.
Insights
Atypical bacterial infections, including Mycoplasma pneumoniae and Chlamydophila pneumoniae, are linked to asthma exacerbations and severity. Further research is needed to understand how these infections impact asthma and the effectiveness of antimicrobial treatments.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Allergy and Immunology
Background:
- Mycoplasma pneumoniae and Chlamydophila pneumoniae are frequently detected in asthma patients.
- Diagnosing these atypical bacterial infections in asthma patients is challenging due to sampling and detection limitations.
- Animal studies suggest these infections can drive allergic lung inflammation and airway remodeling.
Purpose of the Study:
- To review the evidence linking atypical bacterial infections to asthma.
- To discuss the potential mechanisms by which these infections affect asthma.
- To highlight the ongoing investigation into antimicrobial therapies for asthma.
Main Methods:
- Review of existing animal and human studies.
- Analysis of proposed mechanisms of infection-induced asthma.
- Assessment of current research on antimicrobial treatment efficacy.
Main Results:
- Growing human evidence suggests atypical bacterial infections contribute to asthma exacerbations, chronicity, and severity.
- Animal models demonstrate infection-induced allergic lung inflammation and airway remodeling.
- The precise role and effectiveness of antimicrobials in asthma management remain under investigation.
Conclusions:
- Atypical bacterial infections are increasingly implicated in asthma pathogenesis and severity.
- Further research is crucial to elucidate the role of these infections and guide therapeutic strategies.
- The use of antimicrobials for atypical bacterial infections in asthma requires continued investigation.
Related Concept Videos
Atypical Pneumonia
Asthma I: Introduction
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma III: Clinical Manifestations
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.